Role of Omega-3 fatty acids in preventing metabolic disturbances in patients on olanzapine plus either sodium valproate or lithium: a randomized double-blind placebo-controlled trial (Q36564507)
Jump to navigation
Jump to search
scientific article published on 4 October 2012
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Role of Omega-3 fatty acids in preventing metabolic disturbances in patients on olanzapine plus either sodium valproate or lithium: a randomized double-blind placebo-controlled trial |
scientific article published on 4 October 2012 |
Statements
1 reference
Role of Omega-3 fatty acids in preventing metabolic disturbances in patients on olanzapine plus either sodium valproate or lithium: a randomized double-blind placebo-controlled trial (English)
1 reference
Toktam Faghihi
1 reference
Adel Jahed
1 reference
Javad Mahmoudi-Gharaei
1 reference
Vandad Sharifi
1 reference
Padideh Ghaeli
1 reference
4 October 2012
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference